Table 2.
Changes in cognitive scores by treatment arm.
| Cognitive Test | Placebo (N = 14) Mean (SD) |
DHA (N = 15) Mean (SD) |
Difference between treatment arms Mean (95% CI)a |
P-value |
|---|---|---|---|---|
| MoCA | 0.3 (1.6) | −0.2 (1.6) | −0.5 (−1.7, 0.7) | 0.40 |
| Craft immediate recall | 1.7 (3.1) | 0.3 (3.2) | −1.4 (−3.9, 1.0) | 0.23 |
| Craft delayed recall | 0.4 (2.8) | 1.1 (2.8) | 0.7 (−1.5, 2.8) | 0.52 |
| CVLT Trial 5 | −0.8 (2.1) | 1.1 (2.2) | 1.9 (0.2, 3.5) | 0.03 |
| CVLT Trial 5 (ranked) | 9.9 (7.1) | 14.6 (7.2) | 4.7 (−0.8, 10.2) | 0.09 |
| CVLT delayed recall | 1.3 (2.6) | 1.9 (2.6) | 0.6 (−1.4, 2.6) | 0.53 |
| Trails A | −2.8 (10.2) | −3.8 (10.3) | −1.0 (−8.8, 6.9) | 0.80 |
| Trails Bb | −1.5 (40.0) | 3.5 (40.2) | 5.0 (−26.3, 36.3) | 0.74 |
a
Mean difference (DHA minus placebo) in change score.
b
Sample size for Trails B: placebo (N = 14), DHA (N = 14).